Skip to content
  • Home
  • Stock Stories
  • US Equities
  • Ticker Update
  • Equity Analysis
Menu
  • Home
  • Stock Stories
  • US Equities
  • Ticker Update
  • Equity Analysis

NASDAQ:NKTR

[breadcrumb]
Industry

why Nektar Therapeutics [NKTR] is a Good Choice for Investors After New Price Target of $2.88

Annabelle Farmer October 26, 2023
Market

Jefferies slashes price target on Nektar Therapeutics [NKTR] – find out why.

Edison Baldwin October 20, 2023
Industry

Nektar Therapeutics [NKTR] Revenue clocked in at $87.74 million, down -76.11% YTD: What’s Next?

Brandon Evans October 20, 2023
Industry

why Nektar Therapeutics [NKTR] is a Good Choice for Investors After New Price Target of $2.35

Misty Lee September 14, 2023

Company

  • Home
  • About Us
  • Privacy Policy
  • Our Team
  • Contact Us

Categories

  • Stock Stories
  • US Equities
  • Equities Analysis

 

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

© 2022 ALL RIGHTS RESERVED​

We are using cookies to give you the best experience on our website.

You can find out more about which cookies we are using or switch them off in .

The DBT News
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.

Strictly Necessary Cookies

Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.

If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.